Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
565 Effect of non-overlapping mutations in BRAF, NRAS or NF1 on long-term survival after checkpoint inhibitor-based treatment for metastatic melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
